Difference of plasma carnitine levels after at IV infusion and oral carnitine preparation administration and the stopping dosage

Difference of plasma carnitine levels after at IV infusion and oral carnitine preparation administration and the stopping dosage - Carnitine Metabolism in Patients on Hemodialysis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025804

Enrollment

Registered

2017-01-23

Start date

2015-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage kidney disease on HD

Interventions

Change of dosing route of carnitine from P.O. to IV.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: None

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
plasma concentrations of total carnitine(TC),acyl carnitine(AC),free carnitine(FC),and acyl/free carnitine ratio(AC/FC)	—

Countries

Japan

Contacts

Public ContactMasayoshi Nakata

Hakujikai jin clinic Dep.of Nephrology

jincli@hakujikai.org03-3856-7011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026